What is Ipamorelin?
is a synthetic growth hormone–releasing peptide (GHRP). It works by signaling the pituitary gland to release natural growth hormone (GH) pulses through the ghrelin receptor pathway. (Cancer.gov)
In simple terms:
- It does not contain growth hormone
- It tells your body to release more of its own GH in pulses
How it works
Ipamorelin binds to the ghrelin receptor (GHS-R1a) in the pituitary gland, triggering GH release. (PubChem)
Key characteristics in research:
- Selective GH release stimulation
- Minimal effect on cortisol or prolactin (unlike older GHRPs)
- Short half-life (~2 hours) producing brief GH pulses (PubChem)
Why it’s popular in research discussions
It’s often described as a “clean” growth hormone secretagogue because:
- It stimulates GH without strongly affecting hunger or stress hormones
- It mimics natural GH pulsation instead of constant elevation
- It is frequently studied alongside peptides like CJC-1295 (no DAC) for synergy
What “5mg or 10mg vial” means
When you see:
👉 “Ipamorelin 5mg / 10mg vial”
it typically means:
- A freeze-dried (lyophilized) peptide powder
- Total amount of active peptide in the vial
- Intended for laboratory research use only
These are not finished medicines or regulated supplements, and dosing is not standardized for general consumer use.
What it’s studied for
Research interest includes:
- Growth hormone signaling and IGF-1 pathways
- Body composition (fat metabolism and lean tissue support)
- Sleep and recovery physiology
- Anti-aging and endocrine system studies
Important reality check
Even though it’s widely marketed online:
- ❌ Not FDA-approved
- ❌ Not an approved medical treatment
- ❌ No standardized human dosing guidelines for consumer use
- ✔ Classified as a research chemical
Key takeaway
is a growth hormone–releasing research peptide that stimulates natural GH pulses via the ghrelin receptor, but products sold online as “5–10mg vials” are unregulated laboratory materials—not approved medications or supplements.










Reviews
There are no reviews yet.